AstraZeneca to invest $50 billion in the U.S. as pharma tariffs weigh

  • AstraZeneca has become the latest pharma firm to announce a multi-billion investment in the U.S. The Anglo-Swedish biotech firm has committed to spend $50 billion by 2030.